Cecilia Andersson

Dr. Cecilia Andersson

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2011 in Respiratory Research
Verified
Journal Article
Open access
PDF file
CACecilia Andersson
Cecilia Andersson
AAAnnika Andersson-Sjöland
Annika Andersson-Sjöland
MMMichiko Mori
Michiko Mori
OHOskar Hallgren
Oskar Hallgren
APAnnie Pardo
Annie Pardo
JEJonas S Erjefält
Jonas S Erjefält
Background: Although mast cells are regarded as important regulators of inflammation and tissue remodelling, their role in cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF) has remained less studied. This study investigates the densities and phenotypes of mast cell populations in multiple lung compartments from patients with CF, IPF and never smoking controls.Methods: Small airways, pulmonary vessels, and lung parenchyma were subjected to detailed immunohistochemical analyses using lungs from patients with CF (20 lung regions; 5 patients), IPF (21 regions; 7 patients) and controls (16 regions; 8 subjects). In each compartment the densities and distribution of MCTand MCTCmast cell populations were studied as well as the mast cell expression of IL-6 and TGF-β.Results: In the alveolar parenchyma in lungs from patients with CF, MCTCnumbers increased in areas showing cellular inflammation or fibrosis compared to controls. Apart from an altered balance between MCTCand MCTcells, mast cell in CF lungs showed elevated expression of IL-6. In CF, a decrease in total mast cell numbers was observed in small airways and pulmonary vessels. In patients with IPF, a significantly elevated MCTCdensity was present in fibrotic areas of the alveolar parenchyma with increased mast cell expression of TGF-β. The total mast cell density was unchanged in small airways and decreased in pulmonary vessels in IPF. Both the density, as well as the percentage, of MCTCcorrelated positively with the degree of fibrosis. The increased density of MCTC, as well as MCTCexpression of TGF-β, correlated negatively with patient lung function.Conclusions: The present study reveals that altered mast cell populations, with increased numbers of MCTCin diseased alveolar parenchyma, represents a significant component of the histopathology in CF and IPF. The mast cell alterations correlated to the degree of tissue remodelling and to lung function parameters. Further investigations of mast cells in these diseases may open for new therapeutic strategies.

11 June 2013 in Respiratory Research
Verified
Journal Article
Open access
PDF file
MMMichiko Mori
Michiko Mori
CACecilia Andersson
Cecilia Andersson
GGGerard J Graham
Gerard J Graham
CLClaes-Göran Löfdahl
Claes-Göran Löfdahl
JEJonas S Erjefält
Jonas S Erjefält
Background: De novo lymphatic vessel formation has recently been observed in lungs of patients with moderate chronic obstructive pulmonary disease (COPD). However, the distribution of lymphatic vessel changes among the anatomical compartments of diseased lungs is unknown. Furthermore, information regarding the nature of lymphatic vessel alterations across different stages of COPD is missing. This study performs a detailed morphometric characterization of lymphatic vessels in major peripheral lung compartments of patients with different severities of COPD and investigates the lymphatic expression of molecules involved in immune cell trafficking. Methods: Peripheral lung resection samples obtained from patients with mild (GOLD stage I), moderate-severe (GOLD stage II-III), and very severe (GOLD stage IV) COPD were investigated for podoplanin-immunopositive lymphatic vessels in distinct peripheral lung compartments: bronchioles, pulmonary blood vessels and alveolar walls. Control subjects with normal lung function were divided into never smokers and smokers. Lymphatics were analysed by multiple morphological parameters, as well as for their expression of CCL21 and the chemokine scavenger receptor D6. Results: The number of lymphatics increased by 133% in the alveolar parenchyma in patients with advanced COPD compared with never-smoking controls (p < 0.05). In patchy fibrotic lesions the number of alveolar lymphatics increased 20-fold from non-fibrotic parenchyma in the same COPD patients. The absolute number of lymphatics per bronchiole and artery was increased in advanced COPD, but numbers were not different after normalization to tissue area. Increased numbers of CCL21- and D6-positive lymphatics were observed in the alveolar parenchyma in advanced COPD compared with controls (p < 0.01). Lymphatic vessels also displayed increased mean levels of immunoreactivity for CCL21 in the wall of bronchioles (p < 0.01) and bronchiole-associated arteries (p < 0.05), as well as the alveolar parenchyma (p < 0.001) in patients with advanced COPD compared with never-smoking controls. A similar increase in lymphatic D6 immunoreactivity was observed in bronchioles (p < 0.05) and alveolar parenchyma (p < 0.01). Conclusions: This study shows that severe stages of COPD is associated with increased numbers of alveolar lymphatic vessels and a change in lymphatic vessel phenotype in major peripheral lung compartments. This novel histopathological feature is suggested to have important implications for distal lung immune cell traffic in advanced COPD.

15 July 2020 in Allergy
Verified
Journal Article
Open access
PDF file
CACecilia Andersson
Cecilia Andersson
JIJua Iwasaki
Jua Iwasaki
JCJames Cook
James Cook
PRPolly Robinson
Polly Robinson
PNPrasad Nagakumar
Prasad Nagakumar
CLClare M. Lloyd
Clare M. Lloyd
Background: Respiratory syncytial virus (RSV) causes exacerbations of asthma and preschool wheeze (PSW). However, the anti‐viral and repair responses of the bronchial epithelium in children with severe therapy‐resistant asthma (STRA) and PSW are poorly understood.Methods: Children with STRA (age 12 [6‐16] years), PSW (age 2 [1‐5] years) and non‐asthmatic controls (age 7 [2‐14] years) underwent bronchoscopy with endobronchial brushings and biopsies. Anti‐viral, wound injury responses were quantified in biopsies and primary bronchial epithelial cells (PBECs) in response to RSV, poly(I:C), house dust mite (HDM) or IL‐33 using RT‐qPCR, Luminex and live cell imaging. Collagen deposition and tissue expression of epithelial growth factor receptor (EGFR), IL‐33 and receptor ST2 were investigated in bronchial biopsies.Results: PBECs from STRA and PSW had increased TLR3 gene expression and increased secretion of anti‐viral and pro‐inflammatory cytokines (IFN‐γ, IL‐6 and IL‐13) in response to RSV compared to controls. Exposure of PBECs to concomitant TLR3 agonist poly(I:C) and HDM resulted in a significant reduction in epithelial cell proliferation in PSW compared to controls. Wound‐healing was also impaired in PSW compared to controls at baseline and following IL‐33 stimulation. In addition, tissue EGFR expression was significantly reduced in PSW and correlated with collagen deposition in endobronchial biopsies.Conclusions: Despite increased anti‐viral responses, preschool children with severe wheeze had impaired airway epithelial proliferative responses following damage. This might be connected to the low expression of EGFR in PSW which may affect epithelial function and contribute to asthma pathogenesis.

2 June 2021 in BMC Immunology
Verified
Journal Article
Open access
PDF file
SRSangeetha Ramu
Sangeetha Ramu
HAHamid Akbarshahi
Hamid Akbarshahi
SMSofia Mogren
Sofia Mogren
FBFrida Berlin
Frida Berlin
SCSamuel Cerps
Samuel Cerps
CACecilia Andersson
Cecilia Andersson
Background: Mast cells (MCs) are known to contribute to both acute and chronic inflammation. Bronchial epithelial cells are the first line of defence against pathogens and a deficient anti-viral response has been suggested to play a role in the pathogenesis of asthma exacerbations. However, effects of MC mediators on bronchial epithelial immune response have been less studied. The aim of this study is to investigate the direct effects of stimulation with MC proteases, tryptase and chymase, on inflammatory and anti-viral responses in human bronchial epithelial cells (HBECs).Method: Cultured BEAS-2b cells and primary HBECs from 3 asthmatic patients were stimulated with tryptase or chymase (0.1 to 0.5 μg/ml) for 1, 3, 6 and 24 h. To study the effects of MC mediators on the anti-viral response, cells were stimulated with 10 μg/ml of viral mimic Poly (I:C) for 3 and 24 h following pre-treatment with 0.5 μg/ml tryptase or chymase for 3 h. Samples were analysed for changes in pro-inflammatory and anti-viral mediators and receptors using RT-qPCR, western blot and Luminex.Results: Tryptase and chymase induced release of the alarmin ATP and pro-inflammatory mediators IL-8, IL-6, IL-22 and MCP-1 from HBECs. Moreover, tryptase and chymase decreased the expression of E-cadherin and zonula occludens-1 expression from HBECs. Pre-treatment of HBECs with tryptase and chymase further increased Poly (I:C) induced IL-8 release at 3 h. Furthermore, tryptase significantly reduced type-I and III interferons (IFNs) and pattern recognition receptor (PRR) expression in HBECs. Tryptase impaired Poly (I:C) induced IFN and PRR expression which was restored by treatment of a serine protease inhibitor. Similar effects of tryptase on inflammation and anti-viral responses were also confirmed in primary HBECs from asthmatic patients.Conclusion: MC localization within the epithelium and the release of their proteases may play a critical role in asthma pathology by provoking pro-inflammatory and alarmin responses and downregulating IFNs. Furthermore, MC proteases induce downregulation of epithelial junction proteins which may lead to barrier dysfunction. In summary, our data suggests that mast cells may contribute towards impaired anti-viral epithelial responses during asthma exacerbations mediated by the protease activity of tryptase.

1 January 2021 in Cell Adhesion & Migration
Verified
Journal Article
Open access
SMSofia Mogren
Sofia Mogren
FBFrida Berlin
Frida Berlin
SRSangeetha Ramu
Sangeetha Ramu
ASAsger Sverrild
Asger Sverrild
CPCeleste Porsbjerg
Celeste Porsbjerg
CACecilia Andersson
Cecilia Andersson
Epithelial damage and increase of intraepithelial mast cells (MC) are characteristics of asthma. The role of MC mediator tryptase and the protease-activated receptor-2 (PAR2) on epithelial wound healing is not fully investigated. Stimulation of bronchial epithelial cells (BECs) with tryptase promoted gap closure, migration and cellular speed compared to controls. Stimulated BECs had higher expression of migration marker CD151 compared to controls. Proliferation marker KI67 was upregulated in tryptase-stimulated BECs compared to controls. Treatment with PAR2 antagonist I-191 reduced gap closure, migration and cell speed compared to BECs stimulated with tryptase. We found that tryptase enhances epithelial wound healing by increased migration and proliferation, which is in part regulated via PAR2. Our data suggest that tryptase might be beneficial in tissue repair under baseline conditions. However, in a pathological context such as asthma with increased numbers of activated MCs, it might lead to epithelial remodeling and loss of function.

6 December 2017 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
SRS. Ramu
S. Ramu
MMM. Menzel
M. Menzel
LBL. Bjermer
L. Bjermer
CACecilia Andersson
Cecilia Andersson
HAH. Akbarshahi
H. Akbarshahi
LUL. Uller
L. Uller